Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Aminoglygoside nephrotoxicity].

M Baykal

    Mikrobiyoloji Bulteni
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Aminoglycoside nephrotoxicity poses significant risks. This review covers prevention strategies, therapy monitoring, and clinical laboratory findings to mitigate kidney damage from these essential antibiotics.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A case of anesthesia mumps after general anesthesia.

    Acta anaesthesiologica Scandinavica·2009
    Same author

    Diphallus with urethral duplications.

    International urology and nephrology·1999
    Same author

    Comparison of testicular volumes before and after varicocelectomy.

    Urologia internationalis·1998
    Same author

    Diphallus with urethral duplication: a rare case.

    International journal of clinical practice·1998
    Same author

    Burch bladder neck colposuspension, comparison of early and late results.

    Materia medica Polona. Polish journal of medicine and pharmacy·1997
    Same author

    [Staphylococcal biotyping and the use of computers].

    Mikrobiyoloji bulteni·1992
    Same journal

    [Composition of Submucosal Microbiota and Non-Surgical Management of Peri-Implant Diseases].

    Mikrobiyoloji bulteni·2026
    Same journal

    [Pediatric Alveolar Echinococcosis with Pulmonary and Hepatic Involvement and Literature Review: A Rare Case].

    Mikrobiyoloji bulteni·2026
    Same journal

    [Rasamsonia argillacea in Patient with Immunodeficiency: First Suspected Case in Türkiye].

    Mikrobiyoloji bulteni·2026
    Same journal

    [Cutaneous Cryptococcus neoformans Infection Mimicking Necrotizing Fasciitis in a Myelofibrosis Patient Receiving Ruxolitinib: A Case Report].

    Mikrobiyoloji bulteni·2026
    Same journal

    [Kikuchi-Fujimoto Disease Developing after Brucellosis and Leptospirosis Coinfection Presenting with Gastrointestinal System Bleeding: A Case Report].

    Mikrobiyoloji bulteni·2026
    Same journal

    [Non-toxigenic Vibrio cholerae Bacteremia: First Case in Türkiye].

    Mikrobiyoloji bulteni·2026
    See all related articles

    Area of Science:

    • Nephrology
    • Pharmacology
    • Clinical Medicine

    Context:

    • Aminoglycoside antibiotics are crucial for treating severe bacterial infections.
    • Nephrotoxicity is a significant and common adverse effect of aminoglycoside therapy.
    • Managing this toxicity is essential for patient safety and effective treatment.

    Purpose:

    • To review current strategies for preventing aminoglycoside-induced nephrotoxicity.
    • To discuss methods for monitoring aminoglycoside therapy to minimize renal damage.
    • To outline key clinical laboratory findings associated with aminoglycoside nephrotoxicity.

    Summary:

    • This review synthesizes information on preventing kidney damage from aminoglycosides.
    • It details therapeutic drug monitoring techniques and relevant laboratory test results.

    Related Experiment Videos

  • The focus is on practical approaches for clinicians managing patients on these drugs.

    • Impact:

    • Provides clinicians with essential knowledge to reduce the incidence and severity of aminoglycoside nephrotoxicity.
    • Aims to improve patient outcomes by enabling safer and more effective use of aminoglycoside antibiotics.
    • Contributes to the understanding of renal adverse effects associated with critical care medications.